-
CSR Summary
Not Yet Available
-
NCT00553176
-
Primary Citation
-
You are not logged in.
Please login to continue selecting trials.
Trial Information
Generic NameN/AProduct NameREMICADE®Therapeutic AreaRegistryProduct ClassRegistryPharmacological SubgroupRegistryChemical SubgroupRegistryCondition StudiedCrohn's Disease
Sponsor Protocol NumberC0168Z01Enrollment6273Data PartnerJohnson & Johnson% Female58.0%Mean/Median Age (Years)42.5% White89.0%
Supporting Documentation
- Collected Datasets Available
- Data Definition Specification Available
- Protocol with Amendments Available
- Clinical Study Report Available
Approved Data Requests Associated with this Trial
- 2024-0808 : Making Effectiveness Research better by meta-analysing Trial and Real World Evidence in Immune-Mediated inflammatory Diseases (MERMAID)
- 2024-0428 : Development of an Inflammatory Bowel Disease (IBD) patient population dashboard to monitor and improve care through machine learning
- 2024-0356 : Combining clinical trials with external data: applications in the YODA database
